Effect of phosphoric acid on the degradation of human dentin matrix

J Dent Res. 2013 Jan;92(1):87-91. doi: 10.1177/0022034512466264. Epub 2012 Oct 26.

Abstract

This study determined if dentin proteases are denatured by phosphoric acid (PA) used in etch-and-rinse dentin adhesives. Dentin beams were completely demineralized with EDTA for 30 days. We "acid-etched" experimental groups by exposing the demineralized dentin beams to 1, 10, or 37 mass% PA for 15 sec or 15 min. Control beams were not exposed to PA but were incubated in simulated body fluid for 3 days to assay their total endogenous telopeptidase activity, by their ability to solubilize C-terminal crosslinked telopeptides ICTP and CTX from insoluble dentin collagen. Control beams released 6.1 ± 0.8 ng ICTP and 0.6 ± 0.1 ng CTX/mg dry-wt/3 days. Positive control beams pre-incubated in p-aminophenylmercuric acetate, a compound known to activate proMMPs, released about the same amount of ICTP peptides, but released significantly less CTX. Beams immersed in 1, 10, or 37 mass% PA for 15 sec or 15 min released amounts of ICTP and CTX similar to that released by the controls (p > 0.05). Beams incubated in galardin, an MMP inhibitor, or E-64, a cathepsin inhibitor, blocked most of the release of ICTP and CTX, respectively. It is concluded that PA does not denature endogenous MMP and cathepsin activities of dentin matrices.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cathepsins / antagonists & inhibitors
  • Collagen Type I / analysis
  • Collagenases / drug effects
  • Cysteine Proteinase Inhibitors / pharmacology
  • Dentin / drug effects*
  • Dentin / enzymology
  • Dipeptides / pharmacology
  • Enzyme Activators / pharmacology
  • Enzyme Precursors / drug effects
  • Humans
  • Leucine / analogs & derivatives
  • Leucine / pharmacology
  • Materials Testing
  • Matrix Metalloproteinase Inhibitors / pharmacology
  • Matrix Metalloproteinases / drug effects
  • Peptide Hydrolases / drug effects
  • Peptides / analysis
  • Phenylmercuric Acetate / analogs & derivatives
  • Phenylmercuric Acetate / pharmacology
  • Phosphoric Acids / pharmacology*
  • Protein Denaturation
  • Sulfhydryl Reagents / pharmacology
  • Time Factors

Substances

  • Collagen Type I
  • Cysteine Proteinase Inhibitors
  • Dipeptides
  • Enzyme Activators
  • Enzyme Precursors
  • Matrix Metalloproteinase Inhibitors
  • N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide
  • Peptides
  • Phosphoric Acids
  • Sulfhydryl Reagents
  • collagen type I trimeric cross-linked peptide
  • 4-aminophenylmercuriacetate
  • phosphoric acid
  • Cathepsins
  • Peptide Hydrolases
  • Collagenases
  • Matrix Metalloproteinases
  • Leucine
  • Phenylmercuric Acetate
  • E 64